Business Description
Hunan Nucien Pharmaceutical Co Ltd
Share Class Description:
SHSE:688189: Class ACompare
Compare
Traded in other countries / regions
688189.China IPO Date
2020-03-26Description
Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.25 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | 63.05 | |||||
| Interest Coverage | 8.12 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.27 | |||||
| Beneish M-Score | -3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -12.1 | |||||
| 3-Year EBITDA Growth Rate | -32.5 | |||||
| 3-Year EPS without NRI Growth Rate | -65.2 | |||||
| 3-Year Book Growth Rate | -6.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.13 | |||||
| 9-Day RSI | 49.91 | |||||
| 14-Day RSI | 47.47 | |||||
| 6-1 Month Momentum % | -35.43 | |||||
| 12-1 Month Momentum % | -40.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.19 | |||||
| Quick Ratio | 3.11 | |||||
| Cash Ratio | 1.65 | |||||
| Days Inventory | 101.21 | |||||
| Days Sales Outstanding | 398.25 | |||||
| Days Payable | 101.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 14.84 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.71 | |||||
| Operating Margin % | 16.36 | |||||
| Net Margin % | -0.91 | |||||
| FCF Margin % | 37.82 | |||||
| ROE % | -0.38 | |||||
| ROA % | -0.28 | |||||
| ROIC % | 4.71 | |||||
| ROC (Joel Greenblatt) % | 0.59 | |||||
| ROCE % | 0.35 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 24.8 | |||||
| PS Ratio | 2.84 | |||||
| PB Ratio | 1.19 | |||||
| Price-to-Tangible-Book | 1.41 | |||||
| Price-to-Free-Cash-Flow | 7.5 | |||||
| Price-to-Operating-Cash-Flow | 6.3 | |||||
| EV-to-EBIT | 270.74 | |||||
| EV-to-EBITDA | 270.74 | |||||
| EV-to-Revenue | 2.22 | |||||
| EV-to-FCF | 6.01 | |||||
| Price-to-Graham-Number | 1.25 | |||||
| Price-to-Net-Current-Asset-Value | 1.8 | |||||
| Price-to-Net-Cash | 5.92 | |||||
| Earnings Yield (Greenblatt) % | 0.37 | |||||
| FCF Yield % | 13.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hunan Nucien Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 553.209 | ||
| EPS (TTM) (Â¥) | -0.018 | ||
| Beta | 0.96 | ||
| Volatility % | 31.57 | ||
| 14-Day RSI | 47.47 | ||
| 14-Day ATR (Â¥) | 0.260413 | ||
| 20-Day SMA (Â¥) | 5.6895 | ||
| 12-1 Month Momentum % | -40.12 | ||
| 52-Week Range (Â¥) | 5.22 - 11.52 | ||
| Shares Outstanding (Mil) | 274.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hunan Nucien Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hunan Nucien Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hunan Nucien Pharmaceutical Co Ltd Frequently Asked Questions
What is Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189)'s stock price today?
The current price of SHSE:688189 is ¥5.68. The 52 week high of SHSE:688189 is ¥11.52 and 52 week low is ¥5.22.
When is next earnings date of Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189)?
The next earnings date of Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189) is .
Does Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189) pay dividends? If so, how much?
Hunan Nucien Pharmaceutical Co Ltd(SHSE:688189) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers